Stratview Research announces the launch of a new research report on the Onco-Immunotherapy Market: by Epidemiology, By Variation in Therapy, by Class of Drugs (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators and Interferons Alpha), By Diagnosis (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck) , By End-User Location (Hospital, Clinics and Home Based) and by Region (North America, Western Europe, Asia-Pacific, Rest of the World)
This report, from Stratview Research, studies the global onco-immunotherapy market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Global Onco-Immunotherapy Market: Highlights
Oncologists believe that Immunotherapy could be that wonder therapy for cancer. Since 2016, this innovation shifted the way in which cancer is treated and has transformed care for many patients. In fact, ASCO estimates that immune checkpoint inhibitors could save 250,000 years of life for the U.S. patients with advanced lung cancer for whom a checkpoint inhibitor could be prescribed. Immune checkpoint inhibitors are medicines that release the brakes on the body’s immune system, unleashing it to fight cancer.
Click here to request the detailed TOC of the reports:-
https://www.stratviewresearch.com/toc/428/onco-immunotherapy-market.html
OR
Request a sample here:-
https://www.stratviewresearch.com/Request-Sample/428/onco-immunotherapy-market.html
Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body’s natural defenses to fight cancer. It uses substances made by the body or in a laboratory to improve or restore immune system function. This report gives insight on the treatment of cancer patients with immunotherapy across different markets and brings out the gaps between existing way of therapeutics and the demand. It also explores the treatment of different types of cancer i.e. Lung, Breast, Colorectal, Melanoma, Prostate and others using immunotherapy and looks at the regulations, cost, and supply chain issues across the major markets.
The report gives an aerial view of the market for the manufacturers as well as looks at the demands and gaps at the hospitals for suppliers and distributors. Covering all the major markets where immunotherapy has been approved for the treatment of cancer, this report gives a global insight in to the gaps and opportunities that exist in the market.
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
- Market structure: Overview, industry life cycle analysis, supply chain analysis
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
- Market trend and forecast analysis
- Market segment trend and forecast
- Competitive landscape and dynamics: Market share, Product portfolio, New launches, etc.
- Attractive market segments and associated growth opportunities
- Emerging trends
- Strategic growth opportunities for the existing and new players
- Key success factors
- Future outlook
The Burning Questions This Report Will Answer:
- Over 1.5 million people worldwide die from lung cancer per year; why does the disease still has an extremely poor prognosis with all the modern technology?
- What are the options available for accurate prediction of lung cancer?
- Which market is more lucrative pharma, diagnostics or surgery?
- Which technologies are available currently and how will the future technologies disrupt the market?
The Global Onco-Immunotherapy Market is segmented into the following categories:
By Variation in Therapy Algorithm
- APAC
- North America
- Western Europe
- Rest of The World
By Epidemiology
By Class of Drugs
- Monoclonal Antibodies
- Cancer Vaccines
- Check Point Inhibitors &
- Immunomodulators and
- Interferons Alpha)
By Diagnosis
- Lung, Breast
- Colorectal
- Melanoma
- Prostate
- Head & Neck
By End-User Location
- Hospital
- Clinics and
- Home Based
By Region
- North America (Country Analysis: the USA, Canada)
- Western Europe (Country Analysis: Germany, France, the UK)
- Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
- Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others)
Stratview Research has several high value market reports in the healthcare & life science industry. Please refer to the following link to browse through our reports:
https://www.stratviewresearch.com/market/report/Healthcare-and-Life-Sciences.html
About Stratview Research
Stratview Research believes in credible, consistent and cost-effective global healthcare consulting process for its industry partners. University research, Industry R&D, Sales and Marketing team have benefited from our reports, worldwide. Our reports combine evidence-based research with a flavour of deep scientific, therapeutic, clinical and innovative technologies which helps our readers get insights of the brand and marketing trends in the industry, competitive environment and the upcoming disruptors in the market. We have helped clients in market entry, business intelligence, product launches, sales force effectiveness and many other studies through a combination of the off the shelf published reports and highly customized consulting practice.
Stratview Research is a trusted brand globally, providing high quality research and strategic insights that help companies worldwide in effective decision making.
Media Contact
Company Name: Stratview Research
Contact Person: Ritesh Gandecha
Email: Send Email
Phone: +1-313-307-4176
Country: India
Website: www.stratviewresearch.com/